Neoral
Links shared publicly online about this topic
ingentaconnect Nanoparticulate Delivery Can Improve Peroral Bioavailability of C...
ingentaconnect.com — “ingentaconnect Nanoparticulate Delivery Can Improve Peroral Bioavailability of C...” View full resource at ingentaconnect.com
Most Recently Shared on April 24, 2011 at 3:41 am By:
Urology & Nephrology OW Health
Nanoparticulate Delivery Can Improve Peroral Bioavailability of Cyclosporine and Match Neoral Cmax Sparing the K... http://bit.ly/gVrq3Z
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
fda.gov — “The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.” View full resource at fda.gov
Most Recently Shared on July 14, 2009 at 4:05 pm By:
eyeonfda Health Lawyer and Pharma
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants http://bit.ly/40cOo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
